304 related articles for article (PubMed ID: 16054887)
1. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst.
Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Otagiri M
Biochem Biophys Res Commun; 2005 Sep; 334(4):1322-8. PubMed ID: 16054887
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
Rasheed Z; Ali R
Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma.
Rasheed Z; Ahmad R; Rasheed N; Ali R
J Exp Clin Cancer Res; 2007 Sep; 26(3):395-404. PubMed ID: 17987802
[TBL] [Abstract][Full Text] [Related]
4. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients.
Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Tomita K; Otagiri M
Hypertens Res; 2005 Dec; 28(12):973-80. PubMed ID: 16671336
[TBL] [Abstract][Full Text] [Related]
5. Impairments of the biological properties of serum albumin in patients on haemodialysis.
Lim PS; Cheng YM; Yang SM
Nephrology (Carlton); 2007 Feb; 12(1):18-24. PubMed ID: 17295656
[TBL] [Abstract][Full Text] [Related]
6. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies.
Rasheed Z; Ahmad R; Rasheed N; Ali R
Autoimmunity; 2007 Nov; 40(7):512-20. PubMed ID: 17966041
[TBL] [Abstract][Full Text] [Related]
7. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
[TBL] [Abstract][Full Text] [Related]
8. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.
Witko-Sarsat V; Friedlander M; Nguyen Khoa T; Capeillère-Blandin C; Nguyen AT; Canteloup S; Dayer JM; Jungers P; Drüeke T; Descamps-Latscha B
J Immunol; 1998 Sep; 161(5):2524-32. PubMed ID: 9725252
[TBL] [Abstract][Full Text] [Related]
9. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
10. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients.
Mitrogianni Z; Barbouti A; Galaris D; Siamopoulos KC
Nephron Clin Pract; 2009; 113(3):c234-40. PubMed ID: 19690441
[TBL] [Abstract][Full Text] [Related]
11. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
12. The redox state of albumin and serious cardiovascular incidence in hemodialysis patients.
Terawaki H; Takada Y; Era S; Funakoshi Y; Nakayama K; Nakayama M; Ogura M; Ito S; Hosoya T
Ther Apher Dial; 2010 Oct; 14(5):465-71. PubMed ID: 21175544
[TBL] [Abstract][Full Text] [Related]
13. Investigation of albumin properties in patients with chronic renal failure.
Pieniazek A; Brzeszczynska J; Kruszynska I; Gwozdzinski K
Free Radic Res; 2009 Oct; 43(10):1008-18. PubMed ID: 19707919
[TBL] [Abstract][Full Text] [Related]
14. Structure and binding properties of serum albumin in uremic patients at different periods of hemodialysis.
Sarnatskaya VV; Ivanov AI; Nikolaev VG; Rotellar E; von Appen K; Haspar M; Maslenny VN; Klinkmann H
Artif Organs; 1998 Feb; 22(2):107-15. PubMed ID: 9491899
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
16. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
[TBL] [Abstract][Full Text] [Related]
18. Global assessment of serum antioxidant status in hemodialysis patients.
Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N
J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688
[TBL] [Abstract][Full Text] [Related]
19. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
[TBL] [Abstract][Full Text] [Related]
20. Effect of olmesartan on oxidative stress in hemodialysis patients.
Kadowaki D; Anraku M; Tasaki Y; Kitamura K; Wakamatsu S; Tomita K; Gebicki JM; Maruyama T; Otagiri M
Hypertens Res; 2007 May; 30(5):395-402. PubMed ID: 17587751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
